Department of Clinical Psychology and Psychotherapy, University of Erlangen-Nuremberg, Erlangen, Germany.
Department of Clinical Psychology and Psychotherapy, University of Bern, Bern, Switzerland.
Int J Methods Psychiatr Res. 2019 Jun;28(2):e1766. doi: 10.1002/mpr.1766. Epub 2019 Jan 27.
Internet- and mobile-based interventions (IMIs) offer the opportunity to deliver mental health treatments on a large scale. This randomized controlled trial evaluated the efficacy of an unguided IMI (StudiCare SAD) for university students with social anxiety disorder (SAD).
University students (N = 200) diagnosed with SAD were randomly assigned to an IMI or a waitlist control group (WLC) with full access to treatment as usual. StudiCare SAD consists of nine sessions. The primary outcome was SAD symptoms at posttreatment (10 weeks), assessed via the Social Phobia Scale (SPS) and the Social Interaction Anxiety Scale (SIAS). Secondary outcomes included depression, quality of life, fear of positive evaluation, general psychopathology, and interpersonal problems.
Results indicated moderate to large effect sizes in favor of StudiCare SAD compared with WLC for SAD at posttest for the primary outcomes (SPS: d = 0.76; SIAS: d = 0.55, p < 0.001). Effects on all secondary outcomes were significant and in favor of the intervention group.
StudiCare SAD has proven effective in reducing SAD symptoms in university students. Providing IMIs may be a promising way to reach university students with SAD at an early stage with an effective treatment.
基于互联网和移动的干预措施(IMIs)提供了大规模提供心理健康治疗的机会。这项随机对照试验评估了一种无指导的 IMIs(StudiCare SAD)对患有社交焦虑症(SAD)的大学生的疗效。
被诊断患有 SAD 的大学生(N=200)被随机分配到 IMI 组或等待名单对照组(WLC),WLC 可以全面获得常规治疗。StudiCare SAD 由九个疗程组成。主要结局是治疗后(10 周)的 SAD 症状,通过社交恐惧症量表(SPS)和社交互动焦虑量表(SIAS)进行评估。次要结局包括抑郁、生活质量、对积极评价的恐惧、一般精神病理学和人际问题。
结果表明,与 WLC 相比,StudiCare SAD 在治疗后对 SAD 的主要结局(SPS:d=0.76;SIAS:d=0.55,p<0.001)具有中等至较大的效果。干预组在所有次要结局上的效果均显著。
StudiCare SAD 已被证明可有效减轻大学生的 SAD 症状。提供 IMIs 可能是一种有前途的方法,可以在早期阶段用有效的治疗方法接触到患有 SAD 的大学生。